$2,390.00

LNCaP/RFP-Luciferase stable cell line

Catalog number
CL-2152
Description
LNCaP/RFP-Luciferase cells are derived from the human prostate cancer LNCaP cell line by stably integration of a constitutive RFP-Firefly luciferase stably expression construct. LNCaP cells are androgen-sensitive, making them valuable for studying prostate cancer biology and testing potential treatments related to hormone regulation. LNCaP/RFP-Luciferase cells stably stably express RFP and Firefly luciferase, can be used for in vitro assays and in vivo imaging.

Product Details

Package Size 2 x 10^6 cells
Parental cell line LNCaP cells
Transgenic gene RFP, Firefly luciferase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2024, FenicsBIO. All rights reserved.